COMPAGNIE CHARGEURS INVEST (CRI.PA) Stock Fundamental Analysis
EPA:CRI - FR0000130692 - Common Stock
11.55 EUR
+0.07 (+0.61%)
Taking everything into account, CRI scores 3 out of 10 in our fundamental rating. CRI was compared to 15 industry peers in the Industrial Conglomerates industry. Both the profitability and financial health of CRI have multiple concerns. CRI has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
CRI had positive earnings in the past year.
CRI had a positive operating cash flow in the past year.
CRI had positive earnings in 4 of the past 5 years.
In multiple years CRI reported negative operating cash flow during the last 5 years.
1.2 Ratios
CRI has a worse Return On Assets (0.72%) than 66.67% of its industry peers.
The Return On Equity of CRI (2.33%) is worse than 60.00% of its industry peers.
CRI has a Return On Invested Capital (5.11%) which is in line with its industry peers.
CRI had an Average Return On Invested Capital over the past 3 years of 4.65%. This is in line with the industry average of 5.58%.
The 3 year average ROIC (4.65%) for CRI is below the current ROIC(5.11%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.72% | ||
| ROE | 2.33% | ||
| ROIC | 5.11% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
1.3 Margins
CRI has a worse Profit Margin (1.00%) than 73.33% of its industry peers.
In the last couple of years the Profit Margin of CRI has declined.
Looking at the Operating Margin, with a value of 6.54%, CRI is doing worse than 60.00% of the companies in the same industry.
CRI's Operating Margin has been stable in the last couple of years.
CRI's Gross Margin of 28.34% is on the low side compared to the rest of the industry. CRI is outperformed by 80.00% of its industry peers.
CRI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.54% | ||
| PM (TTM) | 1% | ||
| GM | 28.34% |
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRI is destroying value.
CRI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CRI has been increased compared to 5 years ago.
The debt/assets ratio for CRI has been reduced compared to a year ago.
2.2 Solvency
CRI has an Altman-Z score of 1.51. This is a bad value and indicates that CRI is not financially healthy and even has some risk of bankruptcy.
CRI's Altman-Z score of 1.51 is on the low side compared to the rest of the industry. CRI is outperformed by 66.67% of its industry peers.
CRI has a debt to FCF ratio of 14.78. This is a negative value and a sign of low solvency as CRI would need 14.78 years to pay back of all of its debts.
CRI has a Debt to FCF ratio (14.78) which is in line with its industry peers.
CRI has a Debt/Equity ratio of 1.05. This is a high value indicating a heavy dependency on external financing.
CRI's Debt to Equity ratio of 1.05 is on the low side compared to the rest of the industry. CRI is outperformed by 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.05 | ||
| Debt/FCF | 14.78 | ||
| Altman-Z | 1.51 |
ROIC/WACC0.83
WACC6.12%
2.3 Liquidity
CRI has a Current Ratio of 1.25. This is a normal value and indicates that CRI is financially healthy and should not expect problems in meeting its short term obligations.
CRI has a Current ratio of 1.25. This is in the lower half of the industry: CRI underperforms 73.33% of its industry peers.
A Quick Ratio of 0.82 indicates that CRI may have some problems paying its short term obligations.
With a Quick ratio value of 0.82, CRI is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.25 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
CRI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1749.48%, which is quite impressive.
The earnings per share for CRI have been decreasing by -14.59% on average. This is quite bad
The Revenue has grown by 11.85% in the past year. This is quite good.
CRI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.10% yearly.
EPS 1Y (TTM)1749.48%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%518.18%
Revenue 1Y (TTM)11.85%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%15.47%
3.2 Future
The Earnings Per Share is expected to grow by 48.09% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 5.65% on average over the next years.
EPS Next Y68.78%
EPS Next 2Y54.04%
EPS Next 3Y48.09%
EPS Next 5YN/A
Revenue Next Year6.37%
Revenue Next 2Y6.62%
Revenue Next 3Y5.65%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 36.09 indicates a quite expensive valuation of CRI.
Based on the Price/Earnings ratio, CRI is valued a bit more expensive than the industry average as 60.00% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 27.06. CRI is valued slightly more expensive when compared to this.
A Price/Forward Earnings ratio of 15.50 indicates a correct valuation of CRI.
Based on the Price/Forward Earnings ratio, CRI is valued a bit cheaper than 73.33% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.69, CRI is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.09 | ||
| Fwd PE | 15.5 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRI indicates a somewhat cheap valuation: CRI is cheaper than 73.33% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRI indicates a somewhat cheap valuation: CRI is cheaper than 66.67% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.02 | ||
| EV/EBITDA | 7.51 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CRI's earnings are expected to grow with 48.09% in the coming years.
PEG (NY)0.52
PEG (5Y)N/A
EPS Next 2Y54.04%
EPS Next 3Y48.09%
5. Dividend
5.1 Amount
CRI has a Yearly Dividend Yield of 1.13%.
Compared to an average industry Dividend Yield of 14.02, CRI's dividend is way lower than its industry peers. On top of this 80.00% of the companies listed in the same industry pay a better dividend than CRI!
Compared to an average S&P500 Dividend Yield of 2.45, CRI's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.13% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y54.04%
EPS Next 3Y48.09%
EPA:CRI (9/8/2025, 11:38:54 AM)
11.55
+0.07 (+0.61%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)
Earnings (Next)
Inst Owners9.98%
Inst Owner ChangeN/A
Ins Owners64.27%
Ins Owner ChangeN/A
Market Cap287.48M
Analysts75
Price Target13.34 (15.5%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.13% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.86%
PT rev (3m)-2.13%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-31.57%
EPS NY rev (3m)-31.57%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.46%
Revenue NY rev (3m)-2.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.09 | ||
| Fwd PE | 15.5 | ||
| P/S | 0.39 | ||
| P/FCF | 10.02 | ||
| P/OCF | 6.46 | ||
| P/B | 0.92 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.51 |
EPS(TTM)0.32
EY2.77%
EPS(NY)0.75
Fwd EY6.45%
FCF(TTM)1.15
FCFY9.98%
OCF(TTM)1.79
OCFY15.48%
SpS29.31
BVpS12.59
TBVpS-0.27
PEG (NY)0.52
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.72% | ||
| ROE | 2.33% | ||
| ROCE | 6.99% | ||
| ROIC | 5.11% | ||
| ROICexc | 6.21% | ||
| ROICexgc | 14.36% | ||
| OM | 6.54% | ||
| PM (TTM) | 1% | ||
| GM | 28.34% | ||
| FCFM | 3.93% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
ROICexc(3y)5.7%
ROICexc(5y)7.48%
ROICexgc(3y)13.2%
ROICexgc(5y)17.03%
ROCE(3y)6.37%
ROCE(5y)7.53%
ROICexcg growth 3Y-6.3%
ROICexcg growth 5Y2.48%
ROICexc growth 3Y-7.54%
ROICexc growth 5Y-2.79%
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
F-Score7
Asset Turnover0.72
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.05 | ||
| Debt/FCF | 14.78 | ||
| Debt/EBITDA | 4.24 | ||
| Cap/Depr | 52.67% | ||
| Cap/Sales | 2.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 57.27% | ||
| Profit Quality | 393.15% | ||
| Current Ratio | 1.25 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | 1.51 |
F-Score7
WACC6.12%
ROIC/WACC0.83
Cap/Depr(3y)59.11%
Cap/Depr(5y)54.94%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1749.48%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%518.18%
EPS Next Y68.78%
EPS Next 2Y54.04%
EPS Next 3Y48.09%
EPS Next 5YN/A
Revenue 1Y (TTM)11.85%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%15.47%
Revenue Next Year6.37%
Revenue Next 2Y6.62%
Revenue Next 3Y5.65%
Revenue Next 5YN/A
EBIT growth 1Y84.88%
EBIT growth 3Y1%
EBIT growth 5Y4.32%
EBIT Next Year145.94%
EBIT Next 3Y48.76%
EBIT Next 5YN/A
FCF growth 1Y152.76%
FCF growth 3Y-17.92%
FCF growth 5Y170%
OCF growth 1Y253.45%
OCF growth 3Y-11.82%
OCF growth 5Y11.78%